Cathie Wood’s ARK buys CRSP stock, sells ROKU and MASS

Published 09/07/2025, 01:10
Cathie Wood’s ARK buys CRSP stock, sells ROKU and MASS

In the ever-evolving landscape of exchange-traded funds, Cathie Wood’s ARK ETFs remain a focal point for investors seeking exposure to disruptive innovation. The daily trade report for Tuesday, 08 July 2025, showcases ARK’s latest strategic moves, headlined by a significant purchase in CRISPR Therapeutics AG (NASDAQ:CRSP) and sales in 908 Devices Inc (NASDAQ:MASS) and Roku Inc (NASDAQ:ROKU).

The largest transaction of the day was ARK’s acquisition of 102,806 shares of CRISPR Therapeutics AG (NASDAQ:CRSP), valued at approximately $5.26 million. This purchase through the ARKK ETF reflects ARK’s continued confidence in the gene-editing company, which has been a recurring theme in their investment strategy.

On the sell-side, ARK offloaded 62,307 shares of 908 Devices Inc (NASDAQ:MASS) for nearly $399,387 through the ARKG ETF, continuing a selling trend observed over the past week. The sale of 20,813 shares of Roku Inc (NASDAQ:ROKU) through the ARKK ETF, amounting to roughly $1.83 million, also marks a notable reduction in ARK’s position in the streaming device company.

Additionally, ARK made a relatively modest investment in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing just 4 shares for a total of $76 through the ARKK ETF. While the dollar value is minimal, this follows a much larger buy of Beam Therapeutics shares on Monday, indicating a keen interest in the gene-editing firm.

Reviewing ARK’s recent trading activity, it’s evident that ARK has been actively adjusting its holdings. Notably, the fund has been consistently selling shares of 908 Devices Inc (NASDAQ:MASS) and Roku Inc (NASDAQ:ROKU) over the past week, suggesting a strategic shift away from these stocks. Conversely, Beam Therapeutics Inc (NASDAQ:BEAM) has seen an influx of investment from ARK, indicating a bullish outlook on the company’s prospects.

Investors and market watchers continue to monitor Cathie Wood’s ARK ETFs for insights into the next generation of disruptive companies. With each trade, ARK’s investment decisions provide a glimpse into the evolving landscape of innovation-driven markets.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.